My only concern would really be if the FDA started meddling in the MARQUEE trial and halted the study in a similar manner. The MARQUEE trial fully enrolled in the early Spring (if I am not mistaken) and, I thought it enrolled more than anticipated - is the study, this far in, too late for the FDA to halt due to something like ILD?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.